Study on AUNIP as a Novel Tumor Marker for Cervical Cancer

Lin Yuan

Status: Not yet enrolling

Conditions: Cervical Cancer

Treatments: Diagnostic Test: Detection of serum AUNIP expression

Study type: Observational

Funder types: Other

Identifiers

NCT06118463

yl20231001

Details and patient eligibility

About

To detect the expression of AUNIP in cervical cancer serum, and to clarify its diagnostic and prognostic value.

Full description

Blood of all study participants of cervical cancer patients are collected to detect the expression of AUNIP, analyze the statistical correlation between the expression of cervical cancer AUNIP and clinicopathological parameters of patients, and preliminarily understand the expression of AUNIP in cervical cancer tumor tissues and its clinical diagnostic and progniostic value.

Enrollment: 300 estimated patients

Sex: Female

Ages: 20 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Study group inclusion criteria:

• Women aged 20-60
• There is a definite pathological diagnosis of cervical cancer

Healthy control group:

• Women aged 20-60
• No tumors in the uterus or other parts of the body
• No inflammatory disease
• Blood routine and blood biochemical tests are normal

Exclusion criteria

Exclusion criteria of the study group:

• There are other lesions in the uterus and uterine adnexa

Exclusion criteria of healthy control group:

• Pregnant, lactating or menarche women
• Women who are undergoing human papillomavirus (HPV) vaccination

Trial design

300 participants in 2 patient groups

study group

Description:

Women aged 20-60; There is a definite pathological diagnosis of cervical cancer

Treatment:

Diagnostic Test: Detection of serum AUNIP expression

Healthy control group

Description:

Women aged 20-60; No tumors in the uterus or other parts of the body; No inflammatory disease; Blood routine and blood biochemical tests are normal.

Treatment:

Diagnostic Test: Detection of serum AUNIP expression